


Precigen ActoBio Email Formats
Biotechnology Research • Ghent, Flemish Region, Belgium • 1-10 Employees
Precigen ActoBio Email Formats
Precigen ActoBio uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@actobio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@actobio.com | 100% |
Key Contact at Precigen ActoBio
Natasja De Smet
Finance Director
Company overview
| Headquarters | Industriepark Zwijnaarde 7C, Ghent, Flemish Region 9052, BE |
| Website | |
| NAICS | 541714 |
| Keywords | Healthcare, Celiac Disease, Immunotherapy, Therapies, VIB, Type 1 Diabetes, Immunooncology, Targeted Therapy, Treatment Applications |
| Founded | 2006 |
| Employees | 1-10 |
About Precigen ActoBio
Precigen ActoBio™ is a clinical stage biotechnology company pioneering a new class of therapeutic agents created on the ActoBiotics™ platform. These are targeted, microbe-based, specifically designed agents that express and locally deliver potential disease-modifying therapeutics at disease sites including the intestine, the mouth and the nasopharynx, to treat a range of disorders. We have a strong R&D pipeline and an extensive portfolio of candidates advancing toward clinical development across a number of potential indications. Precigen ActoBio™ is a wholly-owned subsidiary of Precigen. More about Precigen ActoBio: https://precigen.com/companies/precigen-actobio/ More about Precigen: https://precigen.com/ For inquiries please contact: abt.info@actobio.com
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Precigen ActoBio has never raised funding before.
Frequently asked questions
4.8
40,000 users



